Jci_page_head_homepage_01 Jci_page_head_homepage_02
Amanda M. Nelson, Wei Zhao, Kathryn L. Gilliland, Andrea L. Zaenglein, Wenlei Liu, Diane M. Thiboutot
Published in Volume 118, Issue 4
J Clin Invest. 2008; 118(4):1468–1478 doi:10.1172/JCI33869
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
TUNEL staining is increased in patients’ sebaceous glands at 1 week of isotretinoin treatment.

Skin sections were obtained from paraffin blocks of 7 patients sampled at baseline and 1 week of isotretinoin and were subjected to TUNEL-peroxidase assay, followed by counterstaining with hematoxylin. At least 2 skin sections from each time point were analyzed from every patient. Patient 7 was omitted from the analysis as no sebaceous glands were found in baseline biopsy sections. Results were quantified by counting TUNEL-positive cells / total cells in sebaceous glands. Representative sections from Patient 4 (Pt. 4) taken at baseline and at 1 week of isotretinoin treatment are shown. TUNEL staining was strongest in the nuclei of sebocytes in the basal layer of the sebaceous gland (arrows) and in early differentiated sebocytes adjacent to the basal layer. Apoptosis was selective for the sebaceous gland, as no apoptosis was detected within the epidermis (not shown). Negative control (NC) consists of sections from a skin specimen treated with DNase I and processed without terminal transferase enzyme. Positive control (PC) consists of sections from a skin specimen treated with DNase I and subjected to the full TUNEL assay. Original magnification, ×400.